Jean Elwing is a Respiratory physician affiliated with University of Cincinnati. OpenAlex indexes 158 publications with 3,310 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Eden Ave
Cincinnati, OH 452194231
Telephone
513-475-8523Registry record last updated 2 Sept 2016.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202543 payments$30,181openpaymentsdata.cms.gov ↗
- Actelion Pharmaceuticals US, Inc.Program year202516 payments$28,186openpaymentsdata.cms.gov ↗
- United Therapeutics CorporationProgram year202535 payments$26,842openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
37.4%Endothelin Receptor Antagonist19.3%Opsumit65%Ambrisentan25%Opsynvi8%Letairis2%Part D<11 patientsLoop diuretic7%Torsemide59%Furosemide41%Part D≥61 patients+ 5 more classes in this area
Metabolism & gastrointestinal
17.2%Proton pump inhibitor7.8%Omeprazole56%Pantoprazole Sodium20%Esomeprazole Magnesium15%Dexlansoprazole Dr10%Part D≥65 patientsH2 blocker6%Famotidine100%Part D≥110 patients+ 4 more classes in this area
Blood & clotting
14.6%Prostacyclin Receptor Agonist10.5%Uptravi100%Part D≥65 patientsProstacycline Vasodilator2.9%Tyvaso Dpi62%Remodulin22%Orenitram Er15%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis
American Journal of Respiratory and Critical Care Medicine
2025 - Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
The Lancet Respiratory Medicine
2024 - Association of Cardiopulmonary Hemodynamics and Mortality in Veterans With Liver Cirrhosis: A Retrospective Cohort Study
Journal of the American Heart Association
2024 - Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization
Annals of Internal Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Alberto Espay, MD
University of Cincinnati
Henry Nasrallah, MD
University of Cincinnati
Elyse Lower, MD
University of Cincinnati
Ahmad Sedaghat, MD, PhD
University of Cincinnati
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”